EpiSign METRIC 5-base: A New Era for Episignature Analysis in Genomics#Canada#London#genomic_analysis#EpiSign#METRIC
EpiSign METRIC 5-base: A New Era for Episignature Analysis in Genomics
EpiSign Inc. has unveiled METRIC 5-base, enhancing episignature analysis across various genomic platforms. A breakthrough for genetic testing.
third-news.com
September 30, 2026 at 1:54 PM
EpiSign METRIC 5-base: A New Era for Episignature Analysis in Genomics#Canada#London#genomic_analysis#EpiSign#METRIC
Global Genomics Services Market Expected to Surge to $24 Billion by 2033#United_States#Wilmington#Precision_Medicine#genomic_analysis#Genomics_Services
Global Genomics Services Market Expected to Surge to $24 Billion by 2033
The Genomics Services Market is estimated to leap from $8.3 billion in 2023 to $24 billion by 2033, driven by technological advancements and increasing demand for tailored medicine.
third-news.com
April 23, 2026 at 3:10 PM
Global Genomics Services Market Expected to Surge to $24 Billion by 2033#United_States#Wilmington#Precision_Medicine#genomic_analysis#Genomics_Services
Droplet Biosciences Advances Cancer Detection Technology Using NVIDIA Innovations#USA#Cambridge#NVIDIA#genomic_analysis#Droplet_Biosciences
Droplet Biosciences Advances Cancer Detection Technology Using NVIDIA Innovations
Droplet Biosciences enhances its cancer detection capabilities with NVIDIA technology, achieving rapid genomic analysis results for improved patient care.
third-news.com
March 3, 2026 at 5:48 PM
Droplet Biosciences Advances Cancer Detection Technology Using NVIDIA Innovations#USA#Cambridge#NVIDIA#genomic_analysis#Droplet_Biosciences
The Cell Clinic Opens in Akasaka, Advancing Stem Cell Treatments with Genomic Analysis#Japan#Tokyo#Stem_Cell_Therapy#Akasaka#genomic_analysis
The Cell Clinic Opens in Akasaka, Advancing Stem Cell Treatments with Genomic Analysis
Located in Akasaka, The Cell Clinic offers tailored stem cell therapies enhanced by genomic analysis, ensuring patient safety and care.
third-news.com
February 25, 2026 at 4:23 AM
The Cell Clinic Opens in Akasaka, Advancing Stem Cell Treatments with Genomic Analysis#Japan#Tokyo#Stem_Cell_Therapy#Akasaka#genomic_analysis
KROMATID Successfully Completes $8 Million Series C Funding, Breaking Growth Targets#United_States#Boulder#funding#genomic_analysis#KROMATID
KROMATID Successfully Completes $8 Million Series C Funding, Breaking Growth Targets
KROMATID has successfully closed an $8 million Series C funding round, exceeding their capital goals and positioning the company for accelerated growth.
third-news.com
August 20, 2025 at 6:18 PM
KROMATID Successfully Completes $8 Million Series C Funding, Breaking Growth Targets#United_States#Boulder#funding#genomic_analysis#KROMATID
Illumina Unveils DRAGEN v4.4 Software for Enhanced Oncology Research and Multiomics#United_States#San_Diego#Illumina_DRAGEN#genomic_analysis#variant_calling
Illumina Unveils DRAGEN v4.4 Software for Enhanced Oncology Research and Multiomics
Illumina has officially launched DRAGEN version 4.4, enhancing clinical oncology research with superior accuracy and user-friendly applications for multiomics workflows.
third-news.com
May 13, 2025 at 2:34 PM
Illumina Unveils DRAGEN v4.4 Software for Enhanced Oncology Research and Multiomics#United_States#San_Diego#Illumina_DRAGEN#genomic_analysis#variant_calling